Senior insider sale
UNITED THERAPEUTICS CORP — senior position signals high conviction
$183.1K
479.00 shares
What this filing means
MESA NILDA plans to sell 479.00 shares of UNITED THERAPEUTICS CORP valued at approximately $183.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/30/2024ACC: 0001950047-24-010093
479.00
Shares to sell
$183.1K
Approx. market value
255.00
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock
Not Applicable
7/13/2024
255.00Total acquired255.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/13/2024 | Restricted Stock Not Applicable | 255.00 | — |
| Total | 255.00 | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
224.00
Market value
$92.4K
11/8/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
255.00
Market value
$90.7K
12/30/2024
Total
Units
479.00
Value
$183.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
11/8/2024 | 224.00 | $92.4K | — | Completed |
| Planned — Approximate Date | ||||
12/30/2024 | 255.00 | $90.7K | NASDAQ | Planned |
| Total | 479.00 | $183.1K | ||